SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-21-365055
Filing Date
2021-12-22
Accepted
2021-12-22 16:45:59
Documents
9
Effectiveness Date
2021-12-22

Document Format Files

Seq Description Document Type Size
1 S-8 d278970ds8.htm S-8 55739
2 EX-5.1 d278970dex51.htm EX-5.1 7820
3 EX-23.1 d278970dex231.htm EX-23.1 1459
4 EX-99.1 d278970dex991.htm EX-99.1 17933
5 EX-99.2 d278970dex992.htm EX-99.2 17854
6 EX-99.3 d278970dex993.htm EX-99.3 30791
7 GRAPHIC g278970g50v66.gif GRAPHIC 6055
8 GRAPHIC g278970g56e31.gif GRAPHIC 3893
9 GRAPHIC g278970g74m60.gif GRAPHIC 1472
  Complete submission text file 0001193125-21-365055.txt   149061
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

IRS No.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-261847 | Film No.: 211513817
SIC: 2834 Pharmaceutical Preparations